NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,339 | -68.9% | 11,864 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $26,813 | -29.4% | 11,864 | 0.0% | 0.00% | +50.0% |
Q3 2022 | $38,000 | -15.6% | 11,864 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $45,000 | -29.7% | 11,864 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $64,000 | -53.6% | 11,864 | +15.7% | 0.00% | -60.0% |
Q4 2021 | $138,000 | -25.0% | 10,250 | 0.0% | 0.01% | -28.6% |
Q3 2021 | $184,000 | +4.5% | 10,250 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $176,000 | -14.1% | 10,250 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $205,000 | +17.8% | 10,250 | 0.0% | 0.01% | -12.5% |
Q4 2020 | $174,000 | +2.4% | 10,250 | 0.0% | 0.01% | +14.3% |
Q3 2020 | $170,000 | -28.3% | 10,250 | 0.0% | 0.01% | -46.2% |
Q2 2020 | $237,000 | +23.4% | 10,250 | -4.5% | 0.01% | -7.1% |
Q1 2020 | $192,000 | -23.2% | 10,730 | -7.4% | 0.01% | 0.0% |
Q4 2019 | $250,000 | -70.0% | 11,587 | -17.0% | 0.01% | -73.6% |
Q4 2017 | $833,000 | +148.7% | 13,952 | 0.0% | 0.05% | +130.4% |
Q3 2017 | $335,000 | +12.0% | 13,952 | -8.7% | 0.02% | +9.5% |
Q2 2017 | $299,000 | -6.3% | 15,283 | +12.5% | 0.02% | -4.5% |
Q1 2017 | $319,000 | +132.8% | 13,587 | +21.4% | 0.02% | +120.0% |
Q4 2016 | $137,000 | -28.6% | 11,195 | 0.0% | 0.01% | -37.5% |
Q3 2016 | $192,000 | +20.8% | 11,195 | 0.0% | 0.02% | +14.3% |
Q2 2016 | $159,000 | +3.2% | 11,195 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $154,000 | -9.9% | 11,195 | +10.2% | 0.01% | -17.6% |
Q4 2015 | $171,000 | +54.1% | 10,160 | 0.0% | 0.02% | +41.7% |
Q3 2015 | $111,000 | – | 10,160 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |